COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 15 of 23 for:    ICATIBANT

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00517582
Recruitment Status : Terminated (This study was stopped to allow initiation of a mult-center study)
First Posted : August 17, 2007
Last Update Posted : December 18, 2015
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Nancy J. Brown, Vanderbilt University

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 2011
Actual Study Completion Date : December 2015